Figure 2. PK of 111 In-basiliximab/DOTA... | American Society of Hematology

Figure 2.

PK of 111In-basiliximab/DOTA in all patients. (A) Clearance of 111In-basiliximab/DOTA from blood over time. (B) Clearance of 111In-basiliximab/DOTA from serum over time. (C) Clearance of 111In-basiliximab/DOTA from urine over time.

PK of ¹¹¹In-basiliximab/DOTA in all patients. (A) Clearance of ¹¹¹In-basiliximab/DOTA from blood over time. (B) Clearance of ¹¹¹In-basiliximab/DOTA from serum over time. (C) Clearance of ¹¹¹In-basiliximab/DOTA from urine over time.

This Feature Is Available To Subscribers Only